BDTX:NASDAQ, Black Diamond Therapeutics, Inc.

BDTX stock overview

Black Diamond Therapeutics, Inc. (BDTX:NASDAQ) closed at $1.31 on November 20, 2026, down 5.76% on the day. It is trading at its 52-week low of $1.31. Over the past year, it lost 65.5%. Black Diamond Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$1.31
Day change
-5.76%
Volume
663,186
Average volume
697,598
Market cap
75M+
52-week range
$1.31 – $3.97
50-day average
$1.80
200-day average
$2.13

Price action over the past year

In 252 trading sessions since November 20, 2025, BDTX closed higher on 114 days (45%). Its best day was May 20, 2026 (+20.00%) and its worst was May 22, 2026 (-35.77%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

BDTX news

About Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer.

Similar stocks

Find more stocks like BDTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.